Breast cancer samples with higher APOBEC3A expression had significantly more APOBEC-driven SGMs compared to cancers with lower expression (P = 1.3 × 10−6, Wilcoxon test) while weaker or subsignificant associations were seen with APOBEC3B expression. This evidence concerns the gene APOBEC3A and breast cancer.